Cargando…

Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model

Osteosarcoma is the most common malignancy of the bones, and although advances in chemotherapy and surgery had been achieved in recent years, the long-term survival rate has reached a plateau. The main reason for this is the aggressive malignant potential and poor response of the disease to chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jian, Guo, Weichun, Wang, Lu, Yu, Ling, Mei, Hongjun, Fang, Shuo, Ji, Peng, Liu, Yang, Liu, Gaiwei, Song, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038486/ https://www.ncbi.nlm.nih.gov/pubmed/27698833 http://dx.doi.org/10.3892/ol.2016.4956

Ejemplares similares

Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail
por: Fang, Shuo, et al.
Publicado: (2016)

Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
por: Yang, Jian, et al.
Publicado: (2017)

The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo
por: Dai, Guo, et al.
Publicado: (2017)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling
por: Yu, Ling, et al.
Publicado: (2016)

Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway
por: Dai, Guo, et al.
Publicado: (2017)

Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells
por: CHENG, ANYUAN, et al.
Publicado: (2016)

Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway
por: Yang, Jian, et al.
Publicado: (2021)

miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1
por: Guo, Xiaodong, et al.
Publicado: (2017)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma via targeting cingulin
por: Liu, Yang, et al.
Publicado: (2021)

The HPB-AML-I cell line possesses the properties of mesenchymal stem cells
por: Ardianto, Bambang, et al.
Publicado: (2010)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity
por: Yu, Ling, et al.
Publicado: (2013)

Stem cells isolated from the human stromal limbus possess immunosuppressant properties
por: Garfias, Yonathan, et al.
Publicado: (2012)

Relationship between red cell distribution width and prognosis of patients with osteosarcoma
por: Zheng, Jian, et al.
Publicado: (2019)

Identification of genes contributing to cisplatin resistance in osteosarcoma cells
por: Xie, Mingzhong, et al.
Publicado: (2022)

Cobalt chloride inhibits tumor formation in osteosarcoma cells through upregulation of HIF-1α
por: ZHANG, BO, et al.
Publicado: (2013)

TMT-based quantitative proteomic analysis of spheroid cells of endometrial cancer possessing cancer stem cell properties
por: Cao, Mingzhu, et al.
Publicado: (2023)

Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties
por: LIU, JIANMING, et al.
Publicado: (2012)

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
por: Yang, Qu, et al.
Publicado: (2021)

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
por: ZHAO, ZHIFANG, et al.
Publicado: (2014)

CD271(+) Osteosarcoma Cells Display Stem-Like Properties
por: Tian, Jiguang, et al.
Publicado: (2014)

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
por: Xu, Liang, et al.
Publicado: (2020)

hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics
por: YU, LING, et al.
Publicado: (2014)

Isaria cicadae conidia possess antiproliferative and inducing apoptosis properties in gynaecological carcinoma cells
por: Sun, Yan-fang, et al.
Publicado: (2017)

Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway
por: Ji, Peng, et al.
Publicado: (2015)

Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression
por: Hu, Konghe, et al.
Publicado: (2020)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

Lgr5(+) amacrine cells possess regenerative potential in the retina of adult mice
por: Chen, Mengfei, et al.
Publicado: (2015)

Ameloblastomas Exhibit Stem Cell Potential, Possess Neurotrophic Properties, and Establish Connections with Trigeminal Neurons
por: Pagella, Pierfrancesco, et al.
Publicado: (2020)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

Targeting the osteosarcoma cancer stem cell
por: Siclari, Valerie A, et al.
Publicado: (2010)

β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1
por: Zhang, Shaochun, et al.
Publicado: (2021)

GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells
por: Zhang, Xinmin, et al.
Publicado: (2016)

miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion
por: Zou, Yonggen, et al.
Publicado: (2018)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors
por: Fujiwara, Shuichi, et al.
Publicado: (2020)

Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin
por: Oka, Naohiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3aitfvbtjdtm4v9ou1qu5dkj7k